Some drug companies cancel assistance programs

As many health policy experts had predicted, some drug companies are now canceling programs designed to help low-income and the otherwise disadvantaged patients obtain medicines following Part D's launch. The impact on many patients with life-threatening diseases such as as AIDS and cancer is turning out to be far more serious than most had anticipated. Expect this story to gain traction next week as additional media outlets pick up on coverage by The Washington Post.

- see this article from The Washington Post

ALSO: An online plea from James Hayes, a 45-year old North Carolina man with AIDS, is one of the reports that brought the story into the spotlight. Post

Post a comment